Skip to main content

Obama Renominates Tavenner to Be CMS Chief


President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it.
If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment.
As illustrated by Dr. Berwick's CMS history, Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by the patient safety expert. Obama had to settle for a temporary recess appointment.
When Dr. Berwick resigned in November 2011, Obama nominated Tavenner. A nurse by training, she came with a well-regarded resume that listed jobs such as group president of outpatient services at hospital giant HCA and secretary of the Virginia Department of Health and Human Resources under former Virginia Governor Tim Kaine. In addition, she had briefly served as acting CMS administrator in 2010 before Dr. Berwick took over.
Her nomination in 2011 did not trigger an outpouring of Republican wrath. House Majority Leader Eric Cantor (R-VA) went so far as to say Tavenner was "eminently qualified" to head CMS. Nevertheless, her first nomination was bottled up in the Senate Finance Committee, and she too became another acting administrator.
Jack Lewin, MD, a healthcare consultant in Washington, DC, and a veteran of organized medicine, told Medscape Medical News that Tavenner's performance so far at CMS should improve her chances of winning over Senate Republicans this time around.
"She has really been a level head who has been juggling an incredible set of circumstances and doing it with amazing decorum and respect," said Dr. Lewin, a former chief executive officer of the American College of Cardiology and the California Medical Association. "That should make her strong in terms of getting confirmed."
Similar to any other president, Obama needs a CMS administrator who is Senate-confirmed, said Dr. Lewin. Otherwise, "it makes things appear unstable and insecure." The lack of a confirmed CMS chief during Obama's first term, he added, made it harder to implement the Affordable Care Act.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volum...
Post a Comment
Read more

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n...
4 comments
Read more